Spinal cord stimulation (SCS) is the most utilized invasive electrical neuromodulation
treatment for the management of refractory chronic pain syndromes. Infection is one of the …

Objectives Allergic reactions are rare and poorly understood complications of
neuromodulation device implantation. There are currently no guidelines for management of …

Background Despite requiring successful trials prior to implantation, spinal cord stimulation
(SCS) systems for pain are often later removed. Removing surgically implanted hardware …

Objectives The aims of this study were to identify the reasons for explanation of spinal cord
stimulator (SCS) devices and to further quantify the proportions and time lines of these …

Objectives A trial of spinal cord stimulation (SCS) is a prerequisite to determine efficacy of
the therapy prior to placement of a permanent implanted system. A trial may be conducted …

Background: The introduction of modern sub-perception modalities has improved the
efficacy of spinal cord stimulation (SCS) in refractory pain syndromes of the trunk and lower …

Background: Spinal cord stimulation (SCS) involves the utilization of an implantable
neurostimulation device, stereotypically used in the treatment of patients with chronic …

Chronic bleeding disorders, allergy to implants, and chronic infections are all complicating
factors when considering neuromodulation therapies. The American Society of Pain and …

The authors describe a case of delayed spastic quadriparesis caused by a peri-electrode
mass following the implantation of a minimally invasive percutaneous spinal cord stimulator …

Abstract Development of an implantable medical device starts with an aim of addressing a
clinical need and improving patient outcomes while minimizing risks. Clinical considerations …